Miyamoto J, Tsuji M, Takeda H, Nawa H, Matsumiya T
Department of Pharmacology and Intractable Disease Research Center, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, 160-8402, Tokyo, Japan.
Eur J Pharmacol. 2000 Dec 1;409(1):81-4. doi: 10.1016/s0014-2999(00)00722-6.
The effects of the selective serotonin (5-hydroxytryptamine (5-HT)) reuptake inhibitor fluvoxamine, given alone or in combination with the benzodiazepine anxiolytic diazepam on the defensive freezing behavior of mice in the conditioned fear stress paradigm were examined. Fluvoxamine (5-20 mg/kg, i.p.) induced a dose-dependent reduction in freezing behavior. In contrast, while low doses of diazepam (0.125 and 0.25 mg/kg, i.p.) reduced the freezing behavior, such effects were not observed with high doses of diazepam (0.5 and 1 mg/kg, i.p.). In the combination study, fluvoxamine (20 mg/kg, i.p. ) did not reduce the freezing behavior in mice that had been pretreated with diazepam (0.125-1 mg/kg, i.p.). None of the doses of fluvoxamine and diazepam used in the present study had any effects on motor activity under non-stressed conditions. These results suggest that benzodiazepines may negatively influence the clinical efficacy of selective 5-HT reuptake inhibitors in the treatment of anxiety disorders.
研究了选择性5-羟色胺(5-羟色胺(5-HT))再摄取抑制剂氟伏沙明单独使用或与苯二氮䓬类抗焦虑药地西泮联合使用对条件性恐惧应激范式中小鼠防御性僵住行为的影响。氟伏沙明(5-20mg/kg,腹腔注射)引起僵住行为的剂量依赖性降低。相比之下,虽然低剂量的地西泮(0.125和0.25mg/kg,腹腔注射)可降低僵住行为,但高剂量的地西泮(0.5和1mg/kg,腹腔注射)则未观察到这种效果。在联合研究中,氟伏沙明(20mg/kg,腹腔注射)对预先用不同剂量地西泮(0.125-1mg/kg,腹腔注射)预处理的小鼠的僵住行为没有降低作用。本研究中使用的氟伏沙明和地西泮的任何剂量在非应激条件下对运动活动均无影响。这些结果表明,苯二氮䓬类药物可能会对选择性5-羟色胺再摄取抑制剂治疗焦虑症的临床疗效产生负面影响。